SynthesisHuman vaccines & immunotherapeutics2013
Economic evaluation of Varicella vaccination: results of a systematic review.
Synthesis in Human vaccines & immunotherapeutics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Pooled it
- Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries.BMC public health · 2015Pooled it
- Assessing the use of antibiotics in pediatric patients hospitalized for varicella.Italian journal of pediatrics · 2022Article
- Long-term vaccine efficacy of a 2-dose varicella vaccine in China from 2011 to 2021: A retrospective observational study.Frontiers in public health · 2022Observational
- Article
- Article
- Clinical characteristics and risk factors associated with breakthrough varicella during varicella outbreaks.Human vaccines & immunotherapeutics · 2020Article
- Budget impact analysis of multiple varicella vaccination strategies: a Mexico perspective.Human vaccines & immunotherapeutics · 2020Article
- Global impact of varicella vaccination programs.Human vaccines & immunotherapeutics · 2019Review
- Varicella vaccination - the global experience.Expert review of vaccines · 2017Review
- Economic evaluations of vaccines in Canada: a scoping review.Cost effectiveness and resource allocation : C/E · 2017Article
- Coverage, efficacy or dosing interval: which factor predominantly influences the impact of routine childhood vaccination for the prevention of varicella? A model-based study for Italy.BMC public health · 2016Article
- Distribution of Health Effects and Cost-effectiveness of Varicella Vaccination are Shaped by the Impact on Herpes Zoster.EBioMedicine · 2015Article
- Standardization of the methods and reference materials used to assess virus content in varicella vaccines.Virology journal · 2015Article
- Effectiveness of vaccination against varicella in children under 5 years in Puglia, Italy 2006-2012.Human vaccines & immunotherapeutics · 2015Article
- How can the results of Health Technology Assessment (HTA) evaluations applied to vaccinations be communicated to decision-makers and stakeholders? The ISPOR Rome Chapter Project.Journal of preventive medicine and hygieneArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe aim of the present study is to review the economic burden of varicella disease and the benefit of universal varicella vaccination in different settings pending its implementation in all Italian regions. MATERIALS AND
methodsResearch was conducted using PubMed, Scopus and ISI databases. Score quality and data extraction were performed for all included studies.
resultsTwenty-three articles met the criteria: 15 cost-effectiveness, 8 cost-benefit and one cost-utility analysis. Varicella vaccination could save the society from €637,762 (infant strategy) to 53 million annually (combined infant and adolescent strategy). The median and the mean quality scores resulted in 91.8% and 85.4% respectively; 11 studies were considered of high quality and 12 of low quality. DISCUSSION: The studies are favorable to the introduction of universal varicella vaccination in Italy, being cost saving and having a positive impact on morbidity. The quality score of the studies varied greatly: recent analyses were of comparable quality to older studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.